8-119416950-C-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 4P and 5B. PM1PM2BP4_StrongBP6
The NM_002514.4(CCN3):c.291C>A(p.Asn97Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00052 in 1,612,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002514.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCN3 | NM_002514.4 | c.291C>A | p.Asn97Lys | missense_variant | 2/5 | ENST00000259526.4 | NP_002505.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCN3 | ENST00000259526.4 | c.291C>A | p.Asn97Lys | missense_variant | 2/5 | 1 | NM_002514.4 | ENSP00000259526.3 | ||
CCN3 | ENST00000520082.1 | n.374C>A | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
ENSG00000286282 | ENST00000670132.1 | n.-3G>T | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.000512 AC: 78AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000616 AC: 153AN: 248436Hom.: 0 AF XY: 0.000565 AC XY: 76AN XY: 134582
GnomAD4 exome AF: 0.000521 AC: 761AN: 1460430Hom.: 0 Cov.: 33 AF XY: 0.000520 AC XY: 378AN XY: 726314
GnomAD4 genome AF: 0.000512 AC: 78AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000456 AC XY: 34AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.291C>A (p.N97K) alteration is located in exon 2 (coding exon 2) of the NOV gene. This alteration results from a C to A substitution at nucleotide position 291, causing the asparagine (N) at amino acid position 97 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at